Article metrics
PDF
Other content recommended for you
- Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
- Why high-risk, non-expected-utility-maximising gambles can be rational and beneficial: the case of HIV cure studies
- Phase I oncology trials: why the therapeutic misconception will not go away
- Newborn health benefits or financial risk protection? An ethical analysis of a real-life dilemma in a setting without universal health coverage
- How to keep high-risk studies ethical: classifying candidate solutions
- An investigation of patients’ motivations for their participation in genetics-related research
- Vaccine testing for emerging infections: the case for individual randomisation
- A rational cure for prereproductive stress syndrome
- Reconceptualising risk–benefit analyses: the case of HIV cure research
- For love and money: the need to rethink benefits in HIV cure studies